Literature DB >> 1355292

Prenatal diagnosis of autosomal dominant polycystic kidney disease using flanking DNA markers and the polymerase chain reaction.

A Turco1, B Peissel, P Quaia, R Morandi, L Bovicelli, P F Pignatti.   

Abstract

A prenatal diagnosis was carried out on a 9-week-old fetus at risk for autosomal dominant polycystic kidney disease (ADPKD). Ten members of the family were previously typed using five DNA markers linked to the PKD1 locus on chromosome 16, and one marker linked to the putative PKD2 locus on chromosome 2. The polymerase chain reaction (PCR) was used to amplify the D16S125 locus. Pairwise and multipoint lod scores indicated that the family was most likely segregating a PKD1 mutation. The fetus inherited the disease haplotype from the affected parent. Diagnostic accuracy was greater than 99 per cent, taking into account the possibility of genetic heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355292     DOI: 10.1002/pd.1970120606

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

1.  DNA microsatellite analysis in families with autosomal dominant polycystic kidney disease (ADPKD): the first Polish study.

Authors:  Agnieszka Binczak-Kuleta; Jacek Rozanski; Leszek Domanski; Marek Myslak; Kazimierz Ciechanowski; Andrzej Ciechanowicz
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

2.  Diagnosis of adult polycystic kidney disease by genetic markers and ultrasonographic imaging in a voluntary family register.

Authors:  R G Elles; K A Hodgkinson; N P Mallick; D J O'Donoghue; A P Read; S Rimmer; E A Watters; R Harris
Journal:  J Med Genet       Date:  1994-02       Impact factor: 6.318

3.  Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease.

Authors:  Stéphanie De Rechter; Jonathan Kringen; Peter Janssens; Max Christoph Liebau; Koenraad Devriendt; Elena Levtchenko; Carsten Bergmann; François Jouret; Bert Bammens; Pascal Borry; Franz Schaefer; Djalila Mekahli
Journal:  PLoS One       Date:  2017-09-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.